Evidence map›Paper›PMID 18989682›Full record

ArticlePediatric surgery international2008

The role of angiotensin II type 1a receptor on intestinal epithelial cells following small bowel resection in a mouse model.

Hiroyuki Koga, Hua Yang, Emir Q Haxhija, Daniel H Teitelbaum

Open access · greenAbstract read
In one paragraph

Article in Pediatric surgery international, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.4field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 3 countries.

Hiroyuki KogaSection of Pediatric Surgery, Department of Surgery, C.S Mott Children's Hospital F3970, University of Michigan Medical School, Ann Arbor, MI 48109-0245, USA.
Hua Yang
Emir Q Haxhija
Daniel H Teitelbaum
University of Michigan–Ann Arbor · USC. S. Mott Children's Hospital · USMedical University of Graz · AT

Funding

TPN INDUCED CHANGES IN INTRAEPITHELIAL LYMPHOCYTESR01AI044076 · NIAID · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI TEITELBAUM, DANIEL H · 2004 to 2014
$3.2M
NIAID NIH HHS 2R01-AI044076-10NIAID NIH HHS R01 AI044076
6 · The paper itself

Abstract

aimWe have previously shown that inhibition of angiotensin converting enzyme (ACE) significantly reduced intestinal epithelial cell (EC) apoptosis and improved morphometric intestinal adaptation in a mouse model of massive small-bowel resection (SBR). This study attempted to further examine the downstream signaling factors in this system by blocking the action of angiotensin II (ATII), hypothesizing that this would lead to similar improvement of intestinal adaptation after SBR.

methodTwo groups of mice (C57BL/6J) underwent either a 60% mid-intestinal resection (SBR group) or a transection/re-anastomosis (Sham group). Because real-time PCR studies showed that only ATII receptor type 1a (ATII-1a) expression was significantly increased after SBR, compared to SHAM mice, we decided to use the specific ATII-1a receptor antagonist Losartan to block this signaling pathway. An additional two groups of mice received daily i.p. injections of Losartan (SBR + Losartan and Sham + Losartan group). At 7 days, the adaptive response was assessed in the remnant gut including villus height, crypt depth, EC apoptosis (TUNEL staining) and proliferation (BrdU incorporation). The apoptotic and proliferation signaling pathways were addressed by analysis of EC mRNA expression.

resultSBR (with and without Losartan) led to a significant increase in villus height and crypt depth. Losartan treatment did not significantly change EC proliferation, but did significantly reduce EC apoptosis rates as compared to the non-treated SBR group. Losartan treatment was associated with a significant reduction of the bax-to-bcl-2 ratio and TNF-alpha expression after SBR compared to non-treated groups. Interestingly, Losartan-treated groups showed a tremendous increase in proliferation of signaling factors EGFR, KGFR and IL7R, which may indicate an expanded potential for further intestinal adaptation also beyond 7 days after SBR.

conclusionThis study showed that the ATII-1a receptor may be of crucial importance for the modulation of intestinal EC apoptosis, and for regulating the post-resectional EC adaptive response.

Indexed as

Adaptation, PhysiologicalAngiotensin II Type 1 Receptor BlockersAnimalsApoptosisCell ProliferationEpithelial CellsIntestinal MucosaIntestine, SmallLosartanMaleMiceMice, Inbred C57BLModels, AnimalReceptor, Angiotensin, Type 1Signal TransductionAngiotensin II Type 1 Receptor BlockersLosartanReceptor, Angiotensin, Type 1

Identifiers

PMID18989682
PMCPMC2814528
OpenAlexW2100735126

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.